BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1371792)

  • 1. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes.
    Hasunuma T; Tsubota H; Watanabe M; Chen ZW; Lord CI; Burkly LC; Daley JF; Letvin NL
    J Immunol; 1992 Mar; 148(6):1841-6. PubMed ID: 1371792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
    Hillman K; Shapira-Nahor O; Gruber MF; Hooley J; Manischewitz J; Seeman R; Vujcic L; Geyer SJ; Golding H
    J Immunol; 1990 Mar; 144(6):2131-9. PubMed ID: 1690235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
    Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
    J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.
    Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE
    J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of HIV-1 by CD4 binding domain reagents and V3-directed monoclonal antibodies.
    Potts BJ; Field KG; Wu Y; Posner M; Cavacini L; White-Scharf M
    Virology; 1993 Nov; 197(1):415-9. PubMed ID: 8212576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
    Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
    J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of soluble recombinant HIV envelope glycoprotein, rgp120, induces conformational changes in the cellular membrane-anchored CD4 molecule.
    Yachou A; Sékaly RP
    Biochem Biophys Res Commun; 1999 Nov; 265(2):428-33. PubMed ID: 10558884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
    Trkola A; Dragic T; Arthos J; Binley JM; Olson WC; Allaway GP; Cheng-Mayer C; Robinson J; Maddon PJ; Moore JP
    Nature; 1996 Nov; 384(6605):184-7. PubMed ID: 8906796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
    Wu L; Gerard NP; Wyatt R; Choe H; Parolin C; Ruffing N; Borsetti A; Cardoso AA; Desjardin E; Newman W; Gerard C; Sodroski J
    Nature; 1996 Nov; 384(6605):179-83. PubMed ID: 8906795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion.
    Burkly LC; Olson D; Shapiro R; Winkler G; Rosa JJ; Thomas DW; Williams C; Chisholm P
    J Immunol; 1992 Sep; 149(5):1779-87. PubMed ID: 1380539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O; Hammache D; Fantini J; Yahi N
    Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
    Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
    Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation.
    Jabado N; Pallier A; Le Deist F; Bernard F; Fischer A; Hivroz C
    J Immunol; 1997 Jan; 158(1):94-103. PubMed ID: 8977179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a structure of the HIV-1 envelope glycoprotein gp120: an immunochemical approach.
    Moore JP; Jameson BA; Sattentau QJ; Willey R; Sodroski J
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):83-8. PubMed ID: 7904352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.
    Cook DG; Fantini J; Spitalnik SL; Gonzalez-Scarano F
    Virology; 1994 Jun; 201(2):206-14. PubMed ID: 8184533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
    Mbemba E; Benjouad A; Saffar L; Gattegno L
    Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
    Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
    Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.